Showing results (151-160 of 282) with videos related to
Sort By:
Pageof 29
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 22, 2011
Many patients with primary sclerosing cholangitis and increased serum levels of carbohydrate antigen 19-9 do not have cholangiocarcinomaEmmanouil Sinakos, Amy K Saenger, Jill Keach, et al.Hepatology (Baltimore, Md.)|March 6, 2008
Mortality attributable to cholestatic liver disease in the United StatesFlavia D Mendes, W Ray Kim, Rachel Pedersen, et al.Scandinavian Journal of Gastroenterology|January 19, 2016
Long-term outcomes in antimitochondrial antibody negative primary biliary cirrhosisGunnar Juliusson, Mohamad Imam, Einar S Björnsson, et al.Liver International : Official Journal of the International Association for the Study of the Liver|December 29, 2016
An update on cancer risk and surveillance in primary sclerosing cholangitisJennifer L Horsley-Silva, Eduardo A Rodriguez, Diana L Franco, et al.Academic Medicine : Journal of the Association of American Medical Colleges|November 1, 2007
Putting the needs of the patient first: Mayo Clinic's core value, institutional culture, and professionalism covenantThomas R Viggiano, Wojciech Pawlina, Keith D Lindor, et al.Gastroenterology|April 3, 2003
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitisDarrell S Pardi, Edward V Loftus, Walter K Kremers, et al.Annals of Hepatology|February 5, 2016
Alkaline phosphatase normalization is a biomarker of improved survival in primary sclerosing cholangitisMoira Hilscher, Felicity B Enders, Elizabeth J Carey, et al.The American Journal of Gastroenterology|April 17, 2007
Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitisEinar Björnsson, Paul AnguloThe American Journal of Gastroenterology|September 9, 2014
Noninvasive prediction of hepatic steatosisJeremy Cumberledge, Paul AnguloPageof 29